Burning Rock Biotech Ltd (BNR) › Operating Cash FlowBurning Rock Biotech Ltd (BNR) — Operating Cash FlowAnnual figures by fiscal year, from SEC filings.2018: -148.78M CNY2019: -228.04M CNY2020: -73.54M CNY2021: -477.89M CNY2022: -456.81M CNY2023: -255.78M CNY2024: -92.26M CNY2025: -28.44M CNY-28.44M CNY2018Operating Cash Flow (CNY)2025Fiscal YearOperating Cash FlowChange YoY2025-28.44M CNY+69.2%2024-92.26M CNY+63.9%2023-255.78M CNY+44.0%2022-456.81M CNY+4.4%2021-477.89M CNY-549.8%2020-73.54M CNY+67.8%2019-228.04M CNY-53.3%2018-148.78M CNY—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsCapital ExpendituresShares OutstandingDividends Per Share